证券代码：002362 证券简称：汉王科技 公告编号：2026-009 特别提示： 汉王科技股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 1、本次股东会无否决、修改、增加提案的情况； 2、本次股东会不涉及变更以往股东会决议的情况。 一、会议召开和出席情况 1、会议召集人：公司董事会 2、会议召开时间：2026 年 2 月 9 日 3、会议地点：公司四楼会议室（北京市海淀区东北旺西路 8 号 5 号楼 汉王大厦） 4、会议主持人：董事长刘迎建先生。 5、会议召开方式：现场表决与网络投票相结合的方式 6、本次会议的召集、召开以及参与表决股东人数均符合《公司法》、 《公司章程》及相关法律法规的规定。 7、会议出席情况 出席本次会议的股东和股东代理人共410人，代表公司股份数为 83,708,470股，占公司有表决权股份总数的34.2429%。其中：现场投票的股 二、提案审议表决情况 出席会议的股东对本次会议的议案进行了认真审议，会议采取记名投 票方式通过了如下决议： 1、审议通过关于公司部分募投项目结项并将节余募 ...

证券代码：002362 证券简称：汉王科技 公告编号：2026-008 汉王科技股份有限公司 关于召开 2026 年第一次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 汉王科技股份有限公司（以下简称"公司"）于 2026 年 1 月 22 日在《证 券时报》《中国证券报》和巨潮资讯网（www.cninfo.com.cn）上刊登了《关 于 召开 2026 年第一次临时股东会的通知》。 1.股东会届次：本次股东会为 2026 年第一次临时股东会。 2.股东会的召集人：董事会。 3.本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章 程》的有关规定。 4.会议时间 现场会议时间：2026 年 2 月 9 日 14：30 — 1 — 网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 2 月 9 日 9:15-9:25，9:30-11:30，13:00-15:00；通过 ...

Core Viewpoint - Hanwang Technology (002362.SZ) forecasts a net loss of 180 million to 220 million yuan for the fiscal year 2025, compared to a loss of 110.16 million yuan in the same period last year [1] Group 1: Financial Performance - The company expects a net profit attributable to shareholders to decline year-on-year, with a projected non-recurring net loss of 189 million to 229 million yuan, compared to a loss of 121.91 million yuan in the previous year [1] Group 2: Reasons for Decline - The decline in performance is attributed to intense competition in the domestic TOC market, leading to decreased sales prices for some products and increased raw material costs, resulting in lower gross margins [1] - Increased R&D expenses due to new product development and technology upgrades, along with higher sales expenses as products like the AI smart reading and writing notebook and AI electronic blood pressure monitor are still in the market development phase [1] - One-time expenses have risen due to management optimization efforts, and significant foreign exchange losses have occurred due to the complex global economic situation and currency fluctuations, particularly affecting the company's export business and dollar-denominated assets [1] - The company plans to make impairment provisions for certain assets based on the cautious principle, considering the industry environment and actual business conditions [1]

Core Viewpoint - Hanwang Technology is forecasting a net loss for the year 2025, with expected net profit attributable to shareholders ranging from -220 million to -180 million yuan, and a net profit excluding non-recurring losses between -229 million and -189 million yuan [1] Group 1: Financial Performance - The company anticipates a year-on-year decline in net profit attributable to shareholders for 2025 [1] - The projected net profit decline is attributed to several factors, including increased competition in the domestic TOC market leading to lower sales prices and rising raw material costs, which have negatively impacted gross margins [1] - The company plans to recognize impairment losses on certain assets based on the cautious principle, in line with industry conditions and actual business situations [1] Group 2: Expenses and Costs - Research and development expenses are expected to increase year-on-year due to new product development and technology upgrades [1] - Sales expenses have risen as products like the AI smart reading and writing notebook and AI electronic blood pressure monitor are still in the market development phase [1] - One-time expenses have increased due to management optimization efforts [1] Group 3: External Factors - The company has a significant proportion of foreign sales and holds certain dollar-denominated assets, making it susceptible to exchange rate fluctuations, which have led to a substantial increase in foreign exchange losses year-on-year [1] - The global economic situation is described as complex, which may further impact the company's financial performance [1]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 证券代码：002362 证券简称：汉王科技 公告编号：2026-006 汉王科技股份有限公司 关于拟对相关资产计提减值准备的公告 | 应收票据坏账损失 | -12.40 | | --- | --- | | 资产减值损失 | 4,075.96 | | 其中:存货跌价损失 | 963.71 | | 无形资产减值损失 | 3,112.25 | | 合计 | 3,876.63 | 二、本次拟计提减值准备的具体情况 （一）信用减值损失 一、本次拟计提资产减值准备情况概述 根据《企业会计准则》、《深圳证券交易所股票上市规则》相关规定， 为更加真实、准确地反映公司的资产价值和财务状况，报告期末，公司对 合并范围内各类资产进行了全面的清查，基于谨慎性原则，根据公司管理 层的提议，拟对部分资产计提减值准备，具体情况如下： 根据《企业会计准则》及《深圳证券交易所股票上市规则》等相关规定， 为更加真实、准确和公允的反映公司资产价值及财务状况，公司及控股子 公司于 2025 年 12 月 31 日对各类资产进行了全面检查，对存在减值迹象 ...

Financial Projections - The estimated net profit for 2025 is projected to be a loss of ¥22,000,000, compared to a loss of ¥18,000,000 in the previous year, and a loss of ¥11,015,950 in the same period last year[3]. - The estimated net profit after deducting non-recurring gains and losses is projected to be a loss of ¥22,900,000, compared to a loss of ¥18,900,000 in the previous year, and a loss of ¥12,191,360 in the same period last year[3]. - The basic earnings per share is expected to be -0.9000, compared to -0.7363 in the previous year, and -0.4506 in the same period last year[3]. - The earnings forecast period is from January 1, 2025, to December 31, 2025[3]. Factors Affecting Profitability - The decline in net profit is attributed to increased competition in the domestic TOC market, leading to lower sales prices and higher raw material costs, resulting in decreased gross margins[5]. - Increased R&D expenses due to new product development and technology upgrades, including AI smart reading and AI electronic blood pressure monitors, which are still in the market expansion phase[5]. - The company has experienced a significant increase in foreign exchange losses due to a large proportion of foreign sales and holding certain dollar assets amidst a complex global economic situation[5]. - The company plans to make impairment provisions for certain assets based on the cautious principle, considering industry conditions and actual business situations[5]. Audit and Investor Guidance - The financial data in this earnings forecast has not been audited by the accounting firm, and there are no discrepancies between the company and the accounting firm regarding the earnings forecast[4]. - Investors are advised to make cautious decisions as the earnings forecast is based on preliminary estimates and the actual financial data will be disclosed in the 2025 annual report[6].

Core Insights - Hanwang Technology officially launched its "Business Partner" program to open its core projects to the market, seeking strategic partners with commercialization capabilities and application scenarios [1][4] - The release of the "AI New Scene Industry White Paper" aims to provide a reference for AI innovation to transition from the laboratory to large-scale applications, emphasizing the need for collaboration in commercial paradigms [1][4] - Hanwang maintains high research and development efficiency and commercialization rates, ensuring that innovation does not stagnate, driven by insights into technology trends and a strategy of incremental product development [1][4] Project Highlights - The forum showcased three key projects: the bionic flapping-wing robot bird, the Kersh audio medical electronic blood pressure monitor, and the dual-mode cholesteric liquid crystal display aimed at new display markets [2][5] - Partners are particularly sought who can bring funding, resources, and application scenarios to accelerate projects in mass production, channel development, compliance certification, and operational delivery [2][5]

Core Viewpoint - The article highlights Hanwang Technology's strategic shift from prototype development to closing the loop in AI applications, aiming to accelerate market entry and establish partnerships for commercialization during the AI application boom [1][3]. Group 1: Company Strategy - Hanwang Technology is actively recruiting commercial partners for verified projects to leverage the current AI application explosion and gain a competitive edge in the industry [1][3]. - The company emphasizes transforming innovation from "papers and demos" into "products and scale," showcasing its ability to navigate the complete cycle of artificial intelligence in China [3][5]. - Hanwang's approach focuses on high R&D efficiency and commercialization rates, ensuring that innovations do not stagnate and are rapidly productized [5][7]. Group 2: Key Projects - Hanwang presented three key projects at the forum: a bionic flapping-wing robot bird, a medical electronic sphygmomanometer, and a dual-mode cholesteric liquid crystal display [8]. - The bionic robot bird has achieved significant technological advancements, positioning Hanwang as the largest commercial manufacturer of intelligent bionic birds globally, with applications in inspection, security, and emergency response [9][11]. - The electronic sphygmomanometer utilizes AI to enhance measurement accuracy, outperforming traditional standards, and aims to integrate with health management applications for long-term value [10][11]. - The dual-mode liquid crystal display combines advantages of traditional LCD and EPD technologies, offering features like eye protection and high refresh rates, which are crucial for differentiation in the AI hardware market [14]. Group 3: Investment Opportunities - The recruitment signals from Hanwang indicate a need for partners who can provide funding, resources, and industry insights to accelerate the commercialization of projects [7][15]. - The focus is on finding partners who can contribute to the industrialization process, emphasizing the importance of speed and scalability in the current AI application landscape [15][16]. - Hanwang's shift from showcasing projects to actively seeking collaboration reflects a strategic move towards co-creation and industrial acceleration rather than mere financing [15][16].

Core Viewpoint - The release of DeepSeek-OCR2 marks a significant disruption in the OCR (Optical Character Recognition) market, which is valued in the hundreds of billions, by introducing a more efficient and cost-effective solution that challenges traditional OCR providers [5][11][18]. Group 1: Product Innovation - DeepSeek-OCR2 introduces a new encoder structure called DeepEncoder-V2, which dynamically adjusts the processing order of visual information based on semantic understanding, enhancing the model's ability to recognize text accurately [6][9]. - The model incorporates a concept of "visual causal flow," allowing it to process images intelligently rather than mechanically, improving its performance in complex layouts and distorted documents [6][9]. - Testing on the OmniDocBench v1.5 benchmark shows that DeepSeek-OCR2 achieved an overall score of 91.09%, a 3.73% improvement over its predecessor, with a notable reduction in reading order accuracy error [7]. Group 2: Cost Efficiency - DeepSeek's pricing model offers a dramatic cost reduction compared to traditional OCR services, with processing costs dropping from approximately $65 to $0.28 for 1,000 pages of complex financial documents, representing a cost difference of over 200 times [12][11]. - The introduction of a token-based billing system allows for even lower costs, potentially as low as $0.028 per document if cached [12]. Group 3: Market Impact - The emergence of DeepSeek-OCR2 threatens established OCR companies like 合合信息, 汉王科技, and ABBYY, as it undermines their claims of specialized expertise and high-value services [13][14]. - Traditional OCR providers, which have relied on proprietary algorithms and extensive template libraries, face a significant challenge as DeepSeek demonstrates that general models can outperform specialized ones without extensive training [14][13]. - The shift towards open-source solutions, as exemplified by DeepSeek-OCR2, is expected to democratize access to OCR technology, enabling small businesses and various sectors to leverage automated document processing [15][16]. Group 4: Future Implications - The release of DeepSeek-OCR2 signifies a transition of OCR technology from a high-cost service to a fundamental infrastructure, akin to utilities like water and electricity, making it accessible to a broader audience [16][18]. - As the cost of machine reading decreases, new opportunities arise in various fields, including small business credit services, automated grading, and intelligent document review processes [15][17]. - The development of a unified multimodal encoder through open-source collaboration is anticipated to accelerate technological advancements and reduce costs across the industry [16].

Core Insights - The Chinese electronic paper tablet market is experiencing a "value return" as consumer behavior shifts towards rationality, focusing on the true utility of products [1] - The market is transitioning from early pulse growth to stable endogenous growth driven by self-disciplined user groups, with a renewed emphasis on "deep reading" and "professional office" needs [1] Market Dynamics - The top four brands in the online market (CR4) accounted for 66.8% of the market share in 2025, an increase of 17.2 percentage points from 2024, indicating a concentration of industry resources towards leading domestic brands like Hanwang and iFLYTEK [3] - The total sales volume of the online all-channel e-reader market is projected to reach 647,000 units in 2025, representing a year-on-year growth of 33.4%, serving as the core engine for market recovery [3] Company Performance - Hanwang Technology's market share in the e-reader segment surged from 14.3% in 2024 to 24.7% in 2025, marking the highest growth rate in the industry, with an annual sales share growth of 69.57% [3] - Hanwang has maintained its position as the sales champion on e-commerce platforms for three consecutive months in the fourth quarter, with its market share reaching 27.0% in December [3] Future Outlook - 2025 is identified as a critical juncture for the high-quality development of China's electronic paper industry, with Hanwang's revival in the e-reader market and deepening involvement in the office AI ecosystem potentially initiating a new long-term growth cycle [3]